{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:12:47Z","timestamp":1760220767892,"version":"build-2065373602"},"reference-count":39,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Using the comprehensive approach to selecting polymorphisms to date, we sought to examine whether recurrence in colorectal cancer was associated with inherited variation in three genes involved in DNA repair and cell proliferation. Three polymorphisms, which are excision repair cross-complementation 1 (ERCC1), xeroderma pigmentosum group D (XPD) and epidermal growth factor receptor (EGFR), were assessed in 257 postoperative stage II\/III CRC patients with 5-fluorouracial chemotherapy in Taiwan. In addition, the correlations between genetic polymorphisms and patients\u2019 clinicopathological features were investigated. Genotypes of XPD codon751 A\/A and ERCC1 codon118 T\/T were associated with regional recurrence in a statistically significant way (p = 0.018). Patients who carried XPD AA and ERCC1 TT genotypes demonstrated a significantly greater regional recurrence risk (OR = 5.625, 95% CI, 1.557\u201320.32). Inherited variation in XPD and ERCC1 was associated with outcome in patients with colorectal cancer in Taiwan. As the significant association of single-nucleotide polymorphisms has not been studied previously in colorectal cancer, these findings suggest novel sites of variation, in part explaining the range of treatment responses seen in this disease.<\/jats:p>","DOI":"10.3390\/ijms14024121","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T04:17:01Z","timestamp":1361852221000},"page":"4121-4134","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome"],"prefix":"10.3390","volume":"14","author":[{"given":"Ming-Yii","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan"},{"name":"Department of Radiation Oncology, Faculty of Medicine, College of Medicine,  Kaohsiung Medical University, Kaohsiung 807, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7705-2621","authenticated-orcid":false,"given":"Jaw-Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Gastrointestinal and General Surgery, Department of Surgery, Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan"},{"name":"Department of Surgery, Faculty of Medicine, Graduate Institute of Medicine, Kaohsiung 807, Taiwan"},{"name":"Department of Medical Genetics, College of Medicine, Kaohsiung Medical University,  Kaohsiung 807, Taiwan"},{"name":"Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Lin","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Colorectal Surgery, Department of Surgery, ZuoYing Armed Forces General Hospital, Kaohsiung 813, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Jen","family":"Chang","sequence":"additional","affiliation":[{"name":"School of Medical and Health Science, Fooyin University, Kaohsiung Hsien 831, Taiwan"},{"name":"Department of Medical Research, Fooyin University Hospital, Pingtung County 928, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiu-Ru","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Medical and Health Science, Fooyin University, Kaohsiung Hsien 831, Taiwan"},{"name":"Department of Medical Research, Fooyin University Hospital, Pingtung County 928, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,2,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(05)17706-X","article-title":"Colorectal cancer","volume":"359","author":"Weitz","year":"2005","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3816\/CCC.2004.n.020","article-title":"Current status of clinical studies for colorectal cancer in Taiwan","volume":"4","author":"Chen","year":"2004","journal-title":"Clin. Color. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/030089160609200504","article-title":"Multiple-target chemotherapy (LV-modulated 5-FU bolus and continuous infusion, oxaliplatin, CPT-11) in advanced 5-FU-refractory colorectal cancer: MTD definition and efficacy evaluation. A phase I-II study","volume":"92","author":"Bonetti","year":"2006","journal-title":"Tumori"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/annonc\/mdg756","article-title":"EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century","volume":"14","author":"Coleman","year":"2003","journal-title":"Ann. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00384-007-0293-z","article-title":"Changes in disease pattern and treatment outcome of colorectal cancer: A review of 5474 cases in 20 years","volume":"22","author":"Ju","year":"2007","journal-title":"Int. J. Color. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.tpj.6500463","article-title":"Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy","volume":"8","author":"Ruzzo","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1349-7006.2008.01031.x","article-title":"ERCC1 codon 118 C\u2192T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma","volume":"100","author":"Chang","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijrobp.2006.03.030","article-title":"Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region","volume":"66","author":"Spindler","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1471-2407-8-169","article-title":"A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment","volume":"8","author":"Goncalves","year":"2008","journal-title":"BMC Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1200\/JCO.2007.12.4602","article-title":"Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancer","volume":"26","author":"Graziano","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1158\/0008-5472.CAN-07-2718","article-title":"Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer","volume":"68","author":"Press","year":"2008","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1245\/s10434-006-9112-y","article-title":"Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene?","volume":"13","author":"Suh","year":"2006","journal-title":"Ann. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1200\/JCO.2006.08.1844","article-title":"Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy","volume":"25","author":"Ruzzo","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jso.2930510304","article-title":"Prognostic markers of colorectal cancer: An evaluation of DNA content, epidermal growth factor receptor, and Ki-67","volume":"51","author":"Hemming","year":"1992","journal-title":"J. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/1078-0432.600.11.2","article-title":"Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation","volume":"11","author":"Zhang","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_16","first-page":"61","article-title":"Characteristics and risk factors for colorectal cancer recurrence","volume":"15","author":"Dogan","year":"2010","journal-title":"J. BUON"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1463-1318.2008.01718.x","article-title":"Growth pattern in the muscular layer reflects the biological behaviour of colorectal cancer","volume":"11","author":"Ueno","year":"2009","journal-title":"Color. Dis."},{"key":"ref_18","first-page":"102","article-title":"Time pattern and prognostic evaluation of the recurrence of rectal cancer after resection","volume":"47","author":"Liu","year":"2009","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00384-008-0540-y","article-title":"Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer","volume":"24","author":"Vather","year":"2009","journal-title":"Int. J. Color. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"679830","DOI":"10.1155\/2009\/679830","article-title":"Prognostic value of microvascular density in Dukes A and B (T1\u2013T4, N0, M0) colorectal carcinomas","volume":"2009","author":"Uribarrena","year":"2009","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_21","first-page":"511","article-title":"Expression of lymphatic vessel endothelial hyaluronan receptor-1 in human colorectal cancer and its clinical significance","volume":"12","author":"Li","year":"2009","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.298.7.754","article-title":"Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer","volume":"298","author":"Meyerhardt","year":"2007","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1200\/JCO.2006.06.0863","article-title":"Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803","volume":"24","author":"Meyerhardt","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1158\/1078-0432.CCR-09-0496","article-title":"Interaction of molecular markers and physical activity on mortality in patients with colon cancer","volume":"15","author":"Meyerhardt","year":"2009","journal-title":"Clin. Cancer. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2014Analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2041-9414-3-3","article-title":"Deficient expression of DNA repair enzymes in early progression to sporadic colon cancer","volume":"3","author":"Facista","year":"2012","journal-title":"Genome Integr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.ejca.2009.03.011","article-title":"E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer","volume":"45","author":"Hebbar","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1158\/1078-0432.CCR-09-0592","article-title":"Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival","volume":"15","author":"Zell","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.bjc.6603630","article-title":"The collagenase-1 (MMP-1) gene promoter polymorphism-1607\/2G is associated with favourable prognosis in patients with colorectal cancer","volume":"96","author":"Hettiaratchi","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_30","first-page":"8654","article-title":"A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer","volume":"61","author":"Park","year":"2001","journal-title":"Cancer Res."},{"key":"ref_31","first-page":"555","article-title":"Comparison of two human ovarian carcinoma cell lines (A2780\/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene","volume":"16","author":"Yu","year":"2000","journal-title":"Int. J. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-04-2216","article-title":"ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin\/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer","volume":"11","author":"Viguier","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.ejca.2008.03.025","article-title":"Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer","volume":"44","author":"Abad","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1200\/JCO.2007.15.8261","article-title":"Survival following recurrence in stage II and III colon cancer: Findings from the ACCENT data set","volume":"26","author":"Campbell","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_35","unstructured":"International Union Against Cancer (2002). TNM Classification of Malignant Tumors, Wiley-Liss, Inc.. [6th ed.]."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2407-8-50","article-title":"ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: A preliminary study","volume":"8","author":"Huang","year":"2008","journal-title":"BMC Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/FPC.0b013e3283415124","article-title":"Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy","volume":"21","author":"Huang","year":"2011","journal-title":"Pharmacogenet. Genomics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.4238\/2011.October.3.4","article-title":"Prospective analysis of KRAS wild-type patients with metastatic colorectal cancer using cetuximab plus FOLFIRI or FOLFOX4 treatment regimens","volume":"10","author":"Huang","year":"2011","journal-title":"Genet. Mol. Res."},{"key":"ref_39","unstructured":"Primer 3. Available online:http:\/\/frodo.wi.mit.edu."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/2\/4121\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:45:01Z","timestamp":1760219101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/2\/4121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,19]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2]]}},"alternative-id":["ijms14024121"],"URL":"https:\/\/doi.org\/10.3390\/ijms14024121","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2013,2,19]]}}}